NATH BIO-GENES (I) LTD
Latest filings
- Trading window closed from Oct 1 until Q2 results are declared · Compliance
- 33rd AGM of Nath Bio-Genes held on Sept 24, 2026; all 5 resolutions passed · Board & Shareholder Meetings
- NSE seeks clarification on quarterly results compliance · Regulatory & Legal
Snapshot
What the business is, and whether it's a good one at a fair price.
Sells hybrid seeds for cotton, paddy, maize and vegetables, along with a smaller line of biopesticides (PNS), to Indian farmers. Cotton and paddy together account for 58% of FY26 revenue (up from 52% in FY25), with maize emerging as the fastest-growing crop at more than 10% of the top line after 54% volume and 78% value growth year-on-year. The company is also building international revenue through an Uzbekistan joint venture, which contributed INR 15 crore in its first year, with a stated medium-term target of 10–15% of consolidated top line. It runs 25,000 MT of cumulative seed storage capacity and works in an India seed market sized at USD 4–4.5bn growing at 12–14% CAGR. FY26 revenue was INR 4,316 million, up 19% YoY, though gross margin normalised to 56% from 63% in FY25 and finance costs rose 38% to INR 133 million as inventory was deliberately built up ahead of the FY27 season. Materials and production inputs are the dominant cost at 68.8% of revenue, while capex is light at 0.7% of revenue. Vegetable seeds and PNS (biopesticides) both contracted in FY26, declining 10% and 17% respectively.
Scorecard
Measured from the filed financials, judged against its Other Agricultural Products peers · as of FY26 — not investment advice
Strengths
Nothing stands out in the filed numbers.Concerns
Charts
How has the market priced it — with filings on the timeline?
NATHBIOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from NATH BIO-GENES (I) LTD's filed financials and exchange disclosures
What does NATH BIO-GENES (I) LTD do?
NATH BIO-GENES (I) LTD is a Agricultural Food & other Products company listed on NSE and BSE, trading under the symbol NATHBIOGEN.
Is NATH BIO-GENES (I) LTD profitable?
Yes. Over the trailing twelve months NATH BIO-GENES (I) LTD reported a net profit of ₹37 Cr on revenue of ₹490 Cr.
Does NATH BIO-GENES (I) LTD pay a dividend?
Yes. The dividend yield is 1.47% at the current price. It paid out 9% of its profit as dividend in FY26.
Is NATH BIO-GENES (I) LTD debt-free?
No. It reported borrowings of ₹139 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹63 Cr after cash. Debt stands at 0.20× equity. That is lower than 56% of its 51 Other Agricultural Products peers.
Is NATH BIO-GENES (I) LTD expensive compared with its peers?
On trailing P/E, NATH BIO-GENES (I) LTD ranks 13 of 53 in Other Agricultural Products — cheaper than 77% of them, against an industry median of 12.6×. This is a position, not a valuation judgement.
How much does the NATH BIO-GENES (I) LTD share price move in a day?
On a typical session NATH BIO-GENES (I) LTD moves 1.35% — that is the median absolute close-to-close move across its last 269 trading days. MarketPing measures each filing's price reaction against it.
Where can I track NATH BIO-GENES (I) LTD's announcements?
Every NSE and BSE filing by NATH BIO-GENES (I) LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.